Gene Therapy for Rheumatoid Arthritis gets Approval to Start Clinical Trials – Labiotech.eu (blog)
|
Gene Therapy for Rheumatoid Arthritis gets Approval to Start Clinical Trials
Labiotech.eu (blog) Arthrogen will start a Phase Ib trial for a gene therapy aiming to treat rheumatoid arthritis with a single injection and reduce costs for patients. Arthrogen, based in Amsterdam, is developing local gene therapies for inflammatory diseases. The … |
